Treatment of Erythema Multiforme with Severe Extensive Mucosal Involvement
Erythema multiforme presenting with severe, extensive mucosal involvement represents a clinically demanding presentation that requires prompt escalation beyond routine outpatient management.
Clinical Scenario
This protocol addresses patients whose mucosal involvement is severe and extensive — a degree of disease that limits oral intake and necessitates inpatient care.
Approach
Management centres on hospitalization with intravenous supportive care and the use of systemic glucocorticoid therapy. Additional specialist consultation may be required depending on the extent of involvement — the full structured regimen is available via the protocol below.
References
DOI: 10.3390/medicina57090921
- In severe disease with extensive mucosal involvement, hospitalization is generally recommended due to limited oral intake.
- Administration of intravenous fluids and electrolyte replacement are recommended.
- Additionally, systemic glucocorticoid therapy may be used, most commonly, prednisone 40–60 mg/d, tapered over 2–4 weeks.
- If ocular involvement is suspected, then ophthalmologic consultation is necessary to prevent serious future complications.
- Ophthalmologists may prescribe ophthalmic medications, such as antibiotic eyedrops, corticosteroid eyedrops, and topical ophthalmic lubricants to aid in recovery and symptom resolution.
View source ↗